Samsung BioLogics covers $2bn IPO on day one
South Korea’s Samsung BioLogics gathered enough orders from investors to cover its W2.25tr ($2.0bn) IPO after the very first day of bookbuilding.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: